Condition: Age-related Macular Degeneration
Interventions: Combination Product: Subcutaneous elamipretide through the elamipretide delivery system; Combination Product: Subcutaneos placebo through the elamipretide delivery system
Sponsor: Stealth BioTherapeutics Inc.
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With GA
May 20, 2019ClinicalTrials.govComments OffOphthalmologyElamipretide | Evaluate | Pharmacokinetics | ReCLAIM2 | SafetyEfficacy | Study | Subjects
Comments



